Benefits of Model-based Drug Development: A Rigorous, Planned Case Study
暂无分享,去创建一个
Wei Xiao | Bradley Ferguson | Russell Reeve | Ruediger Goetz | Marcel Thürk | Seth Berry | R. Reeve | Seth Berry | Ruediger Goetz | M. Thürk | Wei Xiao | Bradley Ferguson
[1] M. Karlsson,et al. Randomized exposure-controlled trials; impact of randomization and analysis strategies. , 2007, British journal of clinical pharmacology.
[2] W Ewy,et al. Model‐based Drug Development , 2007, Clinical pharmacology and therapeutics.
[3] J. DiMasi,et al. Drug development costs when financial risk is measured using the Fama-French three-factor model. , 2009, Health economics.
[4] R. Reeve,et al. Pharmacodynamic Models: Parameterizing the Hill Equation, Michaelis-Menten, the Logistic Curve, and Relationships Among These Models , 2013, Journal of biopharmaceutical statistics.
[6] V. Anisimov. Using Mixed Poisson Models in Patient Recruitment in Multicentre Clinical Trials , 2008 .
[7] L. Endrenyi,et al. Comparative efficiencies of randomized concentration‐ and dose‐controlled clinical trials , 1994, Clinical pharmacology and therapeutics.
[8] M. Walton. The Deming management method , 1986 .
[9] L. Lesko,et al. Optimizing the Science of Drug Development: Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans , 2000, Journal of clinical pharmacology.
[10] Jean‐Paul Squifflet,et al. The pharmacokinetic‐pharmacodynamic relationship for mycophenolate mofetil in renal transplantation , 1998, Clinical pharmacology and therapeutics.
[11] Modelling and Predicting Patient Recruitment in Multi-centre Clinical Trials , 2011 .
[12] Patrick Poulin,et al. Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection. , 2003, Toxicology letters.
[13] V. Anisimov. Predictive Modelling of Recruitment and Drug Supply in Multicenter Clinical Trials , 2009 .
[14] L Aarons,et al. Role of modelling and simulation in Phase I drug development. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[15] L B Sheiner,et al. Learning versus confirming in clinical drug development , 1997, Clinical pharmacology and therapeutics.
[16] Vikram Sinha,et al. Model-Based Drug Development: The Road to Quantitative Pharmacology , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[17] Malcolm Rowland,et al. Optimizing the Science of Drug Development: Opportunities for Better Candidate Selection and Accelerated Evaluation in Humans , 2004, Pharmaceutical Research.